Developmental changes in soluble CD40 ligand

被引:18
作者
Cholette, Jill M. [1 ]
Blumberg, Neil [2 ]
Phipps, Richard P. [3 ]
Mcdermott, Michael P. [4 ]
Gettings, Kelly F. [2 ]
Lerner, Norma B. [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY USA
[2] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY USA
[3] Univ Rochester, Med Ctr, Dept Environm Sci, Rochester, NY USA
[4] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY USA
关键词
D O I
10.1016/j.jpeds.2007.06.036
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives To determine if soluble CD40 ligand (sCD40L;.formally CD154) levels van, with age and to identify age-dependent ranges in healthy pediatric and adult populations. Study design sCD40L was measured in 25 neonates. 74 children (3 months-15 years of age) and 20 adults using air enzyme-linked immunosorbent assay. For age group comparisons, Mann-Whitney tests were performed. Correlation coefficients assessed relationships between plasma and serum sCD40L. Results Plasma sCD40L levels were higher in neonates than in all other age groups, (P <.001). All grouped pediatric plasma levels were significantly higher than in adults (P <.0001). There were no significant differences in plasma sCD40L between pediatric age groups. Serum levels were significantly higher in neonates than in any other age group (P <.0001). Pediatric and adult serum sCD40L levels were not significantly different. Conclusions Plasma sCD40L levels are highest at birth and remain higher than those in adults throughout childhood. Reasons for such developmental changes remain to be investigated. Age-appropriate reference ranges should be used when sCD40L is being evaluated in pediatric disorders.
引用
收藏
页码:50 / 54
页数:5
相关论文
共 30 条
[21]   CD40 ligand binds to α5β1 integrin and triggers cell signaling [J].
Leveille, Claire ;
Bouillon, Marlene ;
Guo, Wen ;
Bolduc, Julie ;
Sharif-Askari, Ehssan ;
El-Fakhry, Youssef ;
Reyes-Moreno, Carlos ;
Lapointe, Rejean ;
Merhi, Yahye ;
Wilkins, John A. ;
Mourad, Walid .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (08) :5143-5151
[22]   Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease [J].
Mason, PJ ;
Chakrabarti, S ;
Albers, AA ;
Rex, S ;
Vitseva, O ;
Varghese, S ;
Freedman, JE .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (10) :1365-1369
[23]   Developmental haemostasis - Impact for clinical haemostasis laboratories [J].
Monagle, P ;
Barnes, C ;
Ignjatovic, V ;
Furmedge, J ;
Newall, F ;
Chan, A ;
De Rosa, L ;
Hamilton, S ;
Ragg, P ;
Robinson, S ;
Auldist, A ;
Crock, C ;
Roy, N ;
Rowlands, S .
THROMBOSIS AND HAEMOSTASIS, 2006, 95 (02) :362-372
[24]   Cardiopulmonary bypass induces release of soluble CD40 ligand [J].
Nannizzi-Alaimo, L ;
Rubenstein, MH ;
Alves, VL ;
Leong, GY ;
Phillips, DR ;
Gold, HK .
CIRCULATION, 2002, 105 (24) :2849-2854
[25]   Atherosclerosis: The emerging role of inflammation and the CD40-CD40 ligand system [J].
Phipps, RP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) :6930-6932
[26]   CD40 ligation induces tissue factor expression in human vascular smooth muscle cells [J].
Schönbeck, U ;
Mach, F ;
Sukhova, GK ;
Herman, M ;
Graber, P ;
Kehry, MR ;
Libby, P .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (01) :7-14
[27]   Soluble CD40L and cardiovascular risk in women [J].
Schönbeck, U ;
Varo, N ;
Libby, P ;
Buring, J ;
Ridker, PM .
CIRCULATION, 2001, 104 (19) :2266-2268
[28]  
Tamura N, 2001, J RHEUMATOL, V28, P2583
[29]   Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis [J].
Viallard, JF ;
Solanilla, A ;
Gauthier, B ;
Contin, C ;
Déchanet, J ;
Grosset, C ;
Moreau, JF ;
Praloran, V ;
Nurden, P ;
Pellegrin, JL ;
Nurden, AT ;
Ripoche, J .
BLOOD, 2002, 99 (07) :2612-2614
[30]   New links between inflammation and thrombosis [J].
Wagner, DD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (07) :1321-1324